检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:左巧云 陶丽群 罗秀[1] 葛文漪[1] 黄仁彬[1]
出 处:《中国实验方剂学杂志》2013年第22期222-226,共5页Chinese Journal of Experimental Traditional Medical Formulae
基 金:广西科学研究与科技开发攻关项目(10124008-6;0992003A-2);广西科技基础条件平台建设项目(12-97-20;10-108-19);广西地方性高发疾病防治研究重点实验室基金(KFJJ2010-22)
摘 要:目的:观察玉郎伞多糖(YLSP)在鸭乙型肝炎病毒(DHBV)持续性感染模型中对鸭血清乙型肝炎病毒DNA的抑制作用及保护肝细胞的作用。方法:将DHBV-DNA强阳性麻鸭随机分为YLSP高、中、低剂量组(10,5,2.5 g·kg-1)、拉米夫定(3TC,0.05 g·kg-1)组和模型组,以上各组每日上午灌胃给药l次,连续14 d。于用药前(T0)、用药7 d(T7)和14 d(T14)及停药后3 d(P3)取静脉血用实时荧光定量PCR检测DHBV-DNA含量,同时采用酶联免疫吸附(ELISA)法测定上清液鸭乙型肝炎病毒表面抗原(DHBsAg)和e抗原(DHBeAg)的滴度;在停药3 d后,取肝脏匀浆,检测肝匀浆液中超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)活性以及丙二醛(MDA)、谷胱甘肽(GSH)的含量。结果:与模型组相比,YLSP高、中剂量治疗组给药7 d(T7)和14 d(T14)即能明显抑制DHBV-DNA复制及血清DHBsAg,DHBeAg的滴度显著降低(P<0.05或P<0.01),停药后3 d(P3),YLSP高剂量组仍能显示出持续有效,血清DHBV-DNA水平及血清DHBsAg,DHBeAg的滴度均无反跳现象(P<0.05或P<0.01);在停药3d后,肝匀浆液中SOD,GSH-Px活性以及MDA,GSH的含量,YLSP高、中剂量组仍能显示出持续有效,没有出现反跳现象(P<0.05或P<0.01)。结论:YLSP具有有效抑制DHBV-DNA和保护肝细胞的作用。Objective:To study the inhibitory effect of Yulangsan polysaccharide (YLSP) on duck hepatitis B virus (DHBV) persistent infection in the model for the serum DHBV-DNA and the protecting effect on hepatocytes.Method:Ducklings were infected with DHBV and randomly divided the 3YLSPS dose groups (10,5,2.5 g ·kg-1),lamivudine (3TC,0.05 g ·kg-1) and model groups respectively,continuous administration for 14 days.The serum content of DHBV-DNA was determined by real time fluorescent quantity polymerase chain reaction (FQ-PCR) method,DHBsAg and DHBeAg in serum were detected by ELISA before treatment and on the 7th,14th day after treatment and At 3 days after stopping treatment,took the liver homogenate and detected in liver and serum superoxide dismutase (SOD),glutathione peroxidase (GSH-Px) activity and malondialdehyde (MDA),L-glutathione (GSH) content.Result:Compared with modle group,the serum levels of DHBV-DNA,DHBsAg and DHBeAg decreased significantly 7 and 14 days after treatment with high-dose and middle-dose YLSP and at 3 days after stopping treatment the DHBV-DNA,DHBsAg and DHBeAg in serum in high-dose group were not rebounded,in liver and serum SOD,GSH-Px activity and MDA,GSH content,high-dose and middle-dose YLSP could still show a sustained and effective,no rebound phenomena (P 〈 O.05 or P 〈 0.01).Conclusion:YLSP can inhibit replication of DHBV and protect hepatocytes.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.49